baber/WOPTO huggingface dataset:
Patent AU-701781-B2 (AU)
Title: ALVAC canarypox virus recombinants comprising heterologous inserts
Inventor: PAOLETTI ENZO
IPC: C12P21/06
Filed: 1997-01-03
Granted: 1999-02-04
Abstract: What is described is a modified vector, such as a recombinant poxvirus, particularly recombinant vaccinia virus, having enhanced safety. The modified recombinant virus has nonessential virus-encoded genetic functions inactivated therein so that virus has attenuated virulence. In one embodiment, the genetic functions are inactivated by deleting an open reading frame encoding a virulence factor. In another embodiment, the genetic functions are inactivated by insertional inactivation of an open reading frame encoding a virulence factor. What is also described is a vaccine containing the modified recombinant virus having nonessential virus-encoded genetic functions inactivated therein so that the vaccine has an increased level of safety compared to known recombinant virus vaccines.\!
Patent AU-660168-B2 (AU)
Title: VP6 encapsulated drug delivery
Inventor: REDMOND MARK J
IPC: A61K47/48
Filed: 1992-01-29
Granted: 1995-06-15
Abstract: Compositions and methods for preparing and delivering encapsulated biologically active agents to specific cell types are disclosed. Substances can be encapsulated in the VP6 inner capsid protein of rotavirus and delivered to selected cells, tissues and organs. Targeting agents can be linked to the surface of the VP6 sphere so that appropriate agents can be delivered to preselected cells and tissue types.
Patent AU-768225-B2 (AU)
Title: A process for the monitoring and diagnostics of data from a remote asset
Inventor: CARDELLA AIDAN
IPC: G06Q10/00
Filed: 2000-10-30
Granted: 2003-12-04
Abstract: A method for processing monitored data from a remote asset to optimize maintenance and operation schedules, the method comprising the steps of collecting data from the remote asset, building a data set based on the data collected, applying statistical scripts to the data set to create a statistical model, comparing the statistical model to the data set, creating a standardization model from the compared statistical model and the data set, applying a trending algorithm to the data, deriving statistical based control limits, and applying the control limits to a new set of collected data.
Patent AU-603203-B2 (AU)
Title: Disinfecting compositions and methods therefor
Inventor: KROSS ROBERT D
IPC: A61K8/42
Filed: 1988-04-13
Granted: 1990-11-08
Abstract: The present invention relates to compositions that are effective oral disinfectants which do not have the strong unpleasant taste of chlorine and are useful in reducing plaque. The invention also concerns processes for making these compositions.
Patent AU-563801-B2 (AU)
Title: Controlling oscillation of spout for charging shaft furnace
Inventor: LEGILLE EDOUARD
IPC: F27D3/10
Filed: 1983-07-06
Granted: 1987-07-23
Abstract: A method and apparatus for controlling the movement of an oscillating spout is presented wherein uneven distribution of spout discharge material is eliminated or at least substantially reduced by a compensating action of varying the angular speed of rotation of the spout in accordance with the angular position of the spout. The present invention is particularly suited for use in conjunction with a charging installation of a shaft furnace, particularly those charging devices having a spout with a cardan suspension system.
Patent AU-610601-B2 (AU)
Title: Tin catalyst obtained from a beta-dicarbonyl compound and a tin salt useful for a silicone composition
Inventor: LETOFFE MICHEL
IPC: C07F7/22
Filed: 1988-06-23
Granted: 1991-05-23
Abstract: An organopolysiloxane composition comprising a base capable of curing by polycondensation reactions and a catalytically effective quantity of a tin catalyst which is the product of reaction of a tin salt with a  beta -dicarbonyl compound. 
<??>The organopolysiloxane composition may be formulated in one or in two packs and can be employed in particular for producing seals in the building industry.
Patent AU-767714-B2 (AU)
Title: Soluble compositions of triphenylethylene antiestrogens
Inventor: KIESVAARA JUHA
IPC: A61K31/138
Filed: 1999-12-16
Granted: 2003-11-20
Abstract: Aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use comprising as a solubility enhancing agent a pharmaceutically acceptable mono- or dicarboxylic acid having 1-5 carbon atoms, wherein the carbon chain may further contain 1-4 hydroxyl, 1-3 oxo, or one or several halogen substituents, or a corresponding anion thereof, or methanesulfonic acid or its corresponding anion, in molar excess with respect to the triphenylethylene antiestrogen, optionally together with an organic water miscible co-solvent such as polyethylene glycol (PEG), propylene glycol, ethanol or isopropanol.
Patent AU-600588-B2 (AU)
Title: Naphthothiazepine derivatives and preparation thereof
Inventor: INOUE HIROZUMI
IPC: B23B27/14
Filed: 1988-07-28
Granted: 1990-08-16
Abstract: A novel naphthpthiazepine derivative of the formula: <CHEM> wherein R<1> is a lower alkoxy group, R<2> is hydrogen atom or a lower alkanoyl group, and R<3> and R<4> are the same or different and hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable acid addition salt thereof, are disclosed. Said derivative (I) and a salt thereof are useful as hypotensive agents and/or coronary or cerebral vasodilators.
Patent AU-605900-B2 (AU)
Title: Profiled plastic band
Inventor: KELDANY RACHID
IPC: F16L11/00
Filed: 1988-08-17
Granted: 1991-01-24
Abstract: A profiled band that includes two longitudinal edges of which one is provided with a groove and a parallel extending rib is allocated to the other one, which mentioned parts form a locked seam when the band is wound to a pipe, which seam is mechanically held in its operational position. The band is specifically suitable for an in situ production of wound pipes having a helically extending seam.
Patent AU-685939-B2 (AU)
Title: DC-89 derivative
Inventor: AMISHIRO NOBUYOSHI
IPC: C07D487/04
Filed: 1995-04-20
Granted: 1998-01-29
Abstract: A DC-89 derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein X represents Cl or Br; R represents (un)substituted alkyl, (un)substituted aralkyl, COR<1> or SO2R<7>; and Y represents the group (a) or (b). The compound has an excellent antitumor activity and is useful as an antitumor drug. <CHEM>
Patent AU-602253-B2 (AU)
Title: Pulse oximetry system
Inventor: HERSH LAWRENCE TOUREK
IPC: A61B5/00
Filed: 1988-10-10
Granted: 1990-10-04
Abstract: A pulse oximetry system is provided in which LEDs (12, 14) of two different wavelengths illuminate tissue containing arterial blood flow. A photodiode (16) receives light from the LEDs and produces electrical signals (IR(t) RED(t)) containing pulsatile components. The components of the two wavelengths are separated and the pulsatile waveforms are monitored until signal peaks (IRmax) are detected at the end of diastole. The waveforms are then integrated over the systolic interval, and the integrals are combined with the signal peak values to determine an index value. The index value is used to select a value representative of oxygen saturation from a look-up table (36).
Patent AU-778486-B2 (AU)
Title: Cell concentration and lysate clearance using paramagnetic particles
Inventor: BITNER REX M
IPC: C12N5/078
Filed: 1999-12-30
Granted: 2004-12-09
Abstract: Methods are disclosed for using paramagnetic particles to concentrate or harvest cells. Methods are also disclosed for clearing a solution of disrupted biological material, such as a lysate of cells or a homogenate of mammalian tissue. Methods are also disclosed for using paramagnetic particles to isolate target nucleic acids, such as RNA or DNA, from a solution cleared of disrupted biological material using the same type or a different type of paramagnetic particle. Kits are also disclosed for use with the various methods of the present invention. Nucleic acids isolated according to the present methods and using the present kits are suitable for immediate use in downstream processing, without further purification.
Patent AU-709049-B2 (AU)
Title: Process and device for contacting a wire conductor
Inventor: FINN DAVID
IPC: G06K19/077
Filed: 1997-02-12
Granted: 1999-08-19
Abstract: Process and device for the contacting of a wire conductor (113) in the course of the manufacture of a transponder unit arranged on a substrate (111) and comprising a wire coil (112) and a chip unit (115), wherein in a first phase the wire conductor (113) is guided away via the terminal area (118, 119) or a region accepting the terminal area and is fixed on the substrate (111) relative to the terminal area (118, 119) or the region assigned to the terminal area, and in a second phase the connection of the wire conductor (113) to the terminal area (118,119) is effected by means of a connecting instrument (125).
Patent AU-727458-B2 (AU)
Title: Color magnetic toner and process for preparing the same
Inventor: NAKATSUKA KATSUTO
IPC: G03G9/083
Filed: 1997-06-06
Granted: 2000-12-14
Abstract: It is to provide a powder for use as a raw material for color magnetic toners for use in a color copier or the like which have been colored vividly as well as in white, and a dry color magnetic toner which is obtained from the raw material. The dry color magnetic toner comprises a powder comprising a light-interference multilayered film formed on a magnetic particle and at least one organic polymer coating film or a colored film on the surface of the powder. The process for producing the dry color magnetic toner comprises coating the surface of the powder having thereon a light-interference multilayered film with at least one organic polymer coating film. <IMAGE>
Patent AU-626540-B2 (AU)
Title: Magnetic protein conjugates, a process for the preparation thereof, and the use thereof
Inventor: HERMENTIN PETER
IPC: G01N33/58
Filed: 1989-03-09
Granted: 1992-08-06
Abstract: The invention relates to magnetic protein conjugates of the general formula I <IMAGE> in which M is a dispersible, magnetically reacting material or particle which carries amino groups, P is a protein which carries one or more mercapto groups, and X is an organic chemical structure which links the two ligands by chemical means, to a process for the preparation of protein conjugates of the formula I and to the use of conjugates of this type for removing cells or soluble bioorganic molecules or components from aqueous salt solutions or body fluids, and to the use thereof in a diagnostic method or as diagnostic aid.
Patent AU-766290-B2 (AU)
Title: Non-covalent bioconjugates useful for diagnosis and therapy
Inventor: RAJAGOPALAN RAGHAVAN
IPC: A61K45/08
Filed: 1999-03-31
Granted: 2003-10-16
Abstract: A composition comprising non-covalent carrier-hapten bioconjugates having the formula HM-----CM wherein HM is a hapten molecule whose molecular weight is generally, but not always, less than 1000 Daltons and is capable of performing specific functions; CM is a carrier molecule, whose molecular weight is generally, but not always, more than 1000 Daltons and is capable of transporting the hapten to a specific site; and the dashed line is a non-covalent bond between the carrier molecule and the hapten molecule. The bioconjugates are formed from cyanine and carrier molecules such as methylated serum albumin, polyarginine, polyaspartic acid, polyglutamic acid, cyclodextrin, and inulin. The bioconjugates are useful in diagnostic and therapeutic medical procedures because they are stable in vitro before being used and stable in vivo during and after use.
Patent AU-612853-B2 (AU)
Title: 2-phenyl-4-oxo-pyrimidopyrimidine derivatives
Inventor: COATES WILLIAM JOHN
IPC: C07D239/30
Filed: 1989-06-14
Granted: 1991-07-18
Abstract: Compounds of the formula (1) : <CHEM> or pharmaceutically acceptable salts are described, wherein R<1> is C1-6alkyl, C2-6alkenyl, C3-5cycloalkylC1-6alkyl, or C1-6alkyl substituted by 1 to 6 fluoro groups; R<2> is C1-6alkylthio, C1-6alkylsulphonyl, C1-6alkoxy, hydroxy, hydrogen, hydrazino, C1-6alkyl, phenyl, -NHCOR<3> wherein R<3> is hydrogen or C1-6alkyl, or -NR<4>R<5>, wherein R<4> and R<5> together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, hexahydroazepino, morpholino or piperazino ring, or R<4> and R<5> are independently hydrogen, C3-5cycloalkyl or C1-6alkyl which is optionally substituted by -CF3, phenyl, -S(O)nC1-6alkyl wherein n is 0, 1 or 2, -OR<6>, -CO2R<7> or -NR<8>R<9> wherein R<6> to R<9> are independently hydrogen or C1-6alkyl, provided that the carbon atom adjacent to the nitrogen atom is not substituted by said -S(O)nC1-6alkyl, -OR<6> or -NR<8>R<9> groups; and <CHEM>  is a ring of sub-formula (a) or (b) : <CHEM> Their use as medicaments, pharmaceutical compositions containing them and processes for their preparation are also described.
Patent AU-768257-B2 (AU)
Title: Free loop knotless suture anchor assembly
Inventor: THAL RAYMOND
IPC: A61B17/56
Filed: 2000-03-09
Granted: 2003-12-04
Abstract: A free loop knotless suture anchor assembly for attachment of tissue to bone mass. The assembly includes a continuous suture loop (92) and an anchor means (105) for capturing portions of the loop with a snag means or recess (107) thereon or therein the anchor means. Once the loop is captured, the anchor is inserted securely into a bone mass (86) which facilitates in a repair of the torn away soft tissue.
Patent AU-758433-B2 (AU)
Title: Variable geometry turbocharger
Inventor: ARNOLD STEVEN DON
IPC: F02B37/24
Filed: 2000-03-13
Granted: 2003-03-20
Abstract: A variable geometry turbocharger employs multiple vanes (36) in the turbine inlet with a unison ring (48) and integral cast wall in the turbine housing forming the nozzle walls. The unison ring incorporates actuation slots (46) receiving tabs (44) on the vanes (36) for opening the closing the nozzle area upon rotation of the unison ring (48). An integral electrohydraulic actuator rotates the unison ring (48) through a rack and pinion driven crank shaft with direct position feedback to the spring biased variable current solenoid via a cam on the crank shaft.
Patent AU-617208-B2 (AU)
Title: Oxime ethers, their preparation and fungicides containing these compounds
Inventor: WENDEROTH BERND
IPC: C07D333/24
Filed: 1989-08-11
Granted: 1991-11-21
Abstract: Oxime ethers of the general formula   <IMAGE> (I)  where R1 and R2 are hydrogen or alkyl, R3 is hydrogen, halogen, cyano, aryl or aryloxy, the aromatic ring being unsubstituted or substituted, or R3 is heteroaryl, adamantyl, fluorenyl or cycloalkyl or cycloalkenyl, these radicals being unsubstituted or substituted, X is saturated or unsaturated C1-C12-alkylene which is unsubstituted or substituted, and n is 0 or 1, and fungicides containing these compounds.
Patent AU-713605-B2 (AU)
Title: Calcification-resistant bioprosthetic tissue and methods of making same
Inventor: LEVY ROBERT J
IPC: A61L27/36
Filed: 1995-10-20
Granted: 1999-12-09
Abstract: Naturally-derived bioprosthetic materials are treated with epoxide crosslinking agents. In some embodiments, the tissue is crosslinked with low molecular weight epoxides in aqueous solutions at high pH levels. In other embodiments, the tissue is crosslinked at physiologic pH levels with epoxide crosslinking agents catalyzed with tertiary or quaternary amines, such as Tris or imidazole. In an advantageous embodiment, bioprosthetic tissue is crosslinked and derivatized with an anticalcification agent, such as a polyphosphonate anticalcification agent, using a polyphosphonate:polyepoxide monoadduct.
Patent AU-632074-B2 (AU)
Title: Pharmaceutical preparation
IPC: A61K38/28
Filed: 1989-11-17
Granted: 1992-12-17
Abstract: This invention relates to a pharmaceutical preparation comprising a combination of one or several receptor/binding proteins (binding growth factors or hormones) and hyaluronic acid (or its derivatives) or a biodegradable polymer, optionally in combination with its/their ligands (growth factors and hormones).
Patent AU-780792-B2 (AU)
Title: Disposable articulated spacing device for surgical treatment of joints of the human body
Inventor: SOFFIATI RENZO
IPC: A61F2/38
Filed: 2001-04-09
Granted: 2005-04-14
Abstract: A disposable articulated spacing device for the treatment of joints of the human body, particularly for temporary replacing an explanted joint prosthesis, comprises at least one first member (2) able to be secured to a first articulation end and at least one second member (3) able to be secured to the other articulation end, both said members (2, 3) being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products; the pre-formed members (2, 3) are reciprocally coupled in an articulated manner to maintain a suitable joint space and at least a partial articulation for the time necessary to perform the further implantation of a joint prosthesis. The biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof. The articulated spacing device maintains a suitable space in the joint seat while allowing a considerable articulated mobility, and re-establishes suitable conditions of implantation of a new permanent joint prosthesis.
Patent AU-659031-B2 (AU)
Title: Network adapter with host indication optimization
Inventor: PETERSEN BRIAN
IPC: H04L29/06
Filed: 1993-07-27
Granted: 1995-05-04
Abstract: Optimized indication signals of a completed data frame transfer are generated by a network adapter which reduces host processor interrupt latency. The network adapter comprises network interface logic for transferring the data frame between the network and a buffer memory and host interface logic for transferring the data frame between the buffer memory and the host system. The network adapter further includes threshold logic where a threshold value in an alterable storage location is compared to a data transfer counter in order to generate an early indication signal. The early indication signal may be used to generate an early interrupt signal to a host processor before a transfer of a data frame is completed. The network adapter also posts status information status registers which may be used by the host processor to tune the timing of the generation of the network adapter interrupt signal.
Patent AU-660852-B2 (AU)
Title: Method of grinding pharmaceutical substances
Inventor: SARPOTDAR PRAMOD P
IPC: G03C1/005
Filed: 1993-09-29
Granted: 1995-07-06
Abstract: A method of preparing particles of a drug substance, which may be a diagnostic imaging agent, which comprises grinding the drug substance in the presence of grinding media comprising a polymeric resin. The method provides particles exhibiting reduced contamination.
Patent AU-621721-B2 (AU)
Title: Trifluromethylphenylazolylmethyloxiranes, the preparation thereof and the use thereof as crop protection agents
Inventor: KARBACH STEFAN
IPC: C07D405/06
Filed: 1990-03-09
Granted: 1992-03-19
Abstract: Trifluoromethylphenylazolylmethyloxiranes of the general formula I <IMAGE>  in which R<1> represents hydrogen, halogen, nitro, phenyl, phenoxy, alkyl, alkoxy, haloalkyl or haloalkoxy, and, moreover, R<1> together with the phenyl ring can also form a naphthyl radical which is unsubstituted or substituted,  n represents an integer from 1 to 5,  R<2> represents ortho- or para-trifluoromethyl,  X represents CH or N, and their acid addition salts and metal salts which are tolerated by plants, and fungicides containing these compounds.
Patent AU-661217-B2 (AU)
Title: Cube-corner retroreflective articles
Inventor: CODERRE JAMES CURTIS
IPC: G02B5/124
Filed: 1993-12-31
Granted: 1995-07-13
Abstract: The retroreflective article (50) has opaque pigment particles (58) dispersed in a retroreflective region (53) of a front portion (55) of a sheeting (52) that includes a body portion (54) and a multitude of cube-corner elements (56). The opaque pigment particles (58) scatter white, yellow, or light brown light to allow the retroreflective article to demonstrate improved lightness and, if coloured fluorescent, improved fluorescence. The improvement in lightness and fluorescence makes the retroreflective articles more conspicuous to persons during the daytime.
Patent AU-695528-B2 (AU)
Title: Full withdrawal container and method
Inventor: WEILER GERHARD H
IPC: B65D33/06
Filed: 1996-05-30
Granted: 1998-08-13
Abstract: The present invention relates to a method of forming a container (10) having an upper end neck (14) with a cylindrical barrel for receiving a withdrawal instrument (25, 46), and having a collar (20) internally projecting at the lower portion thereof, and terminating with a stop (21) therebeneath to accurately gauge the penetration of the withdrawal instrument (25, 46), characterised by the steps of forming a mandrel for insertion into a parison which has been partially blown having an upper neck portion in which a stop is provided above the base of the neck, forming a friction fit ring from a recess in the mandrel and proportioning a radius and draft angle which permit the mandrel to be withdrawn from the thus-formed product without damaging the ring and stop but after they have been sufficiently formed to permit the withdrawal of the mandrel. <IMAGE>
Patent AU-573430-B2 (AU)
Title: Missile reprogramming
Inventor: HUI KENNETH H
IPC: G06F9/445
Filed: 1986-03-17
Granted: 1988-06-09
Abstract: A system for providing information to alter the software of an electronic data processor embedded in an electronic module includes a remote reprogramming module that conducts a sequence of operations to provide data to the processor which the processor uses to reprogram itself. The system employs a data link having a bi-directional transmission path connecting the processor and the reprogramming module. A controlled switching circuit is provided at each end of the transmission path. Under normal operating conditions, the transmission path is used to transit a function signal for a function performed by the electronic module. Periodically, the processor operates one switching network to capture the path for transmission of a reprogramming inquiry signal to the reprogramming module. At the same time, the function signal is diverted to an alternate path internal to the electronic module. When the reprogramming module detects a reprogramming inquiry, it operates the other switching circuit to gain access to the transmission path. Then, in response to commands from the processor, the reprogramming module undertakes the reprogramming sequence and transfers data to alter program information held in the memory of the processor. Thereafter, both the processor and the reprogramming module operate their respective switching circuits to restore the transmission path to its normal operational use for the transmission of the function signal.